Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.82)
# 2,920
Out of 4,829 analysts
169
Total ratings
42.03%
Success rate
-2.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $95.21 | -0.22% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $536.51 | +21.15% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $3.08 | +62.34% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $11.97 | +0.25% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $137.70 | -5.59% | 15 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $111.50 | -14.80% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $83.48 | +17.39% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $95.75 | -11.23% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $28.91 | -48.11% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $310.67 | +10.41% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $3.37 | +315.43% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $30.90 | +55.34% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $73.68 | +38.44% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $102.86 | -43.61% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $11.27 | +77.46% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $84.67 | +54.72% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $133.24 | -0.18% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $380.92 | -42.25% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $125.11 | +202.13% | 2 | Feb 25, 2022 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $95.21
Upside: -0.22%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $536.51
Upside: +21.15%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.08
Upside: +62.34%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $11.97
Upside: +0.25%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $137.70
Upside: -5.59%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $111.50
Upside: -14.80%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $83.48
Upside: +17.39%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $95.75
Upside: -11.23%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $28.91
Upside: -48.11%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $310.67
Upside: +10.41%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $3.37
Upside: +315.43%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $30.90
Upside: +55.34%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $73.68
Upside: +38.44%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $102.86
Upside: -43.61%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $11.27
Upside: +77.46%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $84.67
Upside: +54.72%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $133.24
Upside: -0.18%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $380.92
Upside: -42.25%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $125.11
Upside: +202.13%